tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Emily Bodnar, 344 are a BUY (88.89%), 43 are a HOLD (11.11%).
Analyst Emily Bodnar, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 30.45% that have a potential upside of 52.11% achieved within 117 days.
Emily Bodnar’s has documented 670 price targets and ratings displayed on 34 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TGTX, TG Therapeutics at 01-Sep-2026.
Analyst best performing recommendations are on SQZ (SQZ BIOTECHNOLOGIES CO).
The best stock recommendation documented was for OLMA (OLEMA PHARMACEUTICALS) at 10/20/2025. The price target of $28 was fulfilled within 37 days with a profit of $20.23 (260.36%) receiving and performance score of 70.37.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 09-Aug-2023
$48
$0.45 (0.95%)
$48
3 years 1 months 23 days ago
(09-Aug-2023)
1/8 (12.5%)
$0.45 (0.95%)
85
Hold Since 26-Jun-2023
$56
3 years 3 months 6 days ago
(26-Jun-2023)
0/1 (0%)
$27.35 (95.46%)
Buy Since 22-May-2023
$48
3 years 3 months 11 days ago
(21-Jun-2023)
0/2 (0%)
$1.56 (3.36%)
Buy Since 14-Sep-2022
$48
$0.45 (0.95%)
$68
3 years 3 months 12 days ago
(20-Jun-2023)
1/3 (33.33%)
$1.56 (3.36%)
27
Hold Since 24-May-2023
$48
$0.45 (0.95%)
$38
3 years 3 months 12 days ago
(20-Jun-2023)
1/2 (50%)
$1.56 (3.36%)
27
Which stock is Emily Bodnar most bullish on?
Which stock is Emily Bodnar most reserved on?
What Year was the first public recommendation made by Emily Bodnar?
